Thymic humoral factor receptor (THFR)

The Thymic humoral factor receptor (THFR) is a cell-surface receptor primarily located on thymus-derived T cells that mediates the immunomodulatory effects of Thymic Humoral Factor (THF), specifically the synthetic octapeptide THF-gamma2 (Yakir et al., 1992). It is functionally characterized as being coupled to the membrane-bound enzyme adenylyl cyclase; upon activation by its ligand, it induces a rapid increase in intracellular cyclic AMP (cAMP) levels (Trainin et al., 1985). This signaling pathway is critical for the differentiation of immature T-cell precursors into mature, functional lymphocytes and the enhancement of their ability to produce cytokines like Interleukin-2 (Burstein et al., 1988). Historically, the receptor has been targeted by the synthetic peptide THF-gamma2 in clinical trials aimed at treating secondary immunodeficiencies, such as those caused by HIV infection or chemotherapy-induced immunosuppression (Handzel et al., 1990). Despite its physiological significance, the receptor's specific molecular structure and gene sequence have not been definitively cloned or categorized within the modern G protein-coupled receptor (GPCR) nomenclature, representing a challenge for contemporary drug discovery. Its primary role remains the regulation of the adaptive immune response through the modulation of T-cell maturation and effector function.

Other names

THF receptorThymic humoral factor-gamma 2 receptorTHF-gamma2 receptorAdenylyl cyclase-coupled THF receptor

Agonist-induced activation of membrane-bound adenylyl cyclase, leading to increased intracellular cyclic AMP (cAMP) levels which promote T-cell differentiation and cytokine production.